Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GanoHerb is a consumer health and nutraceutical company focused on organic reishi mushroom and other mushroom-based wellness products rather than a drug-development biotech pipeline. The company says it operates an integrated value chain spanning Ganoderma lucidum strain selection, organic cultivation, extraction, production, testing, and global sales. Its commercial portfolio includes reishi spore products, mushroom coffees, teas, capsules, and other functional supplements sold under the GANOHERB brand. The group appears to originate from Fujian, China, with a U.S. operating entity, GanoHerb International Inc., established to market products in the United States. Based on available public information, GanoHerb is best characterized as an active commercial natural health products company, not a clinical-stage pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GanoHerb.